Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

stocktitan.net / Share Newsitem

View, share or embed this newsitem using the details below.
Groundbreaking antiviral discovery: Bioxytran's Prolectin-M blocks viral attachment, shows promise against COVID-19 and other viruses. Learn how this galectin-targeting approach could revolutionize treatment and impact the $147B market.
Continue
Please wait ...